Stratus Medical, a leading healthcare company dedicated to improving clinical outcomes for chronic pain patients, is pleased to announce the expansion of patent protection in Europe for its groundbreaking NIMBUS Electrosurgical RF Multitined Expandable Electrode. This innovative technology aims to revolutionize the treatment of pain by advancing radiofrequency (RF) technology.
With the issuance of European Patent Numbers EP3556308 and EP3750501, Stratus Medical now holds expanded patent protection in the United Kingdom, Ireland, Spain, France, Germany, Italy, and all other countries under the Unitary Patent system. This significant milestone adds to the company’s global patent portfolio, which currently includes 37 grants and five pending applications and registrations.
In addition to expanding patent protection, Stratus Medical has also registered a Community design with the European Union Intellectual Property Office for its forthcoming platform technology, which is currently in late-stage development. While this platform technology has not yet received regulatory clearance from the FDA or the CE Mark, Stratus Medical is confident in its potential to further enhance pain relief for patients.
Bret Boudousquie, the CEO of Stratus Medical, emphasized the company’s commitment to protecting its RF ablation technologies and future innovations. He stated, “These recently issued European patents are particularly important as we continue to gain momentum with NIMBUS in Europe.” Stratus Medical’s dedication to research and development is evident through its ongoing investment in technology that aligns with its mission of improving clinical outcomes and providing substantial savings for customers.
NIMBUS, in combination with a radiofrequency generator and thermocouple probe, offers an efficient and effective solution for RF heat lesion procedures to alleviate pain. The technology has been FDA cleared and CE marked, demonstrating its safety and efficacy. Independent clinical studies have validated its ability to deliver durable and sustained pain relief while reducing procedure time.
Stratus Medical, headquartered in Magnolia, Texas, remains at the forefront of innovation in the field of pain management. With its expanded patent protection and ongoing development efforts, Stratus Medical is poised to make a significant impact in improving the lives of chronic pain patients worldwide.
For media inquiries, please contact:
Cody Jorgensen
Director, Marketing
Stratus Medical
Phone: 346-703-0642
Email: [email protected]
Website: https://stratusmedical.com
The article announces that Stratus Medical has expanded its patent protection for its NIMBUS Electrosurgical RF Multitined Expandable Electrode in Europe. The company now holds European patent protection in countries such as the United Kingdom, Ireland, Spain, France, Germany, and Italy, among others. This expansion is a significant milestone for Stratus Medical, adding to its global patent portfolio, which already consists of 37 grants and five pending applications and registrations.
In addition to the patent expansion, Stratus Medical has registered a Community design with the European Union Intellectual Property Office for its forthcoming platform technology, which is currently in late-stage development. Although this platform technology has not yet received regulatory clearance from the FDA or the CE Mark, Stratus Medical believes in its potential to enhance pain relief for patients.
The CEO of Stratus Medical, Bret Boudousquie, emphasizes the company’s commitment to protecting its RF ablation technologies and future innovations. He sees the recently issued European patents as especially important as the company gains momentum with NIMBUS in Europe. Stratus Medical continues to invest in research and development in line with its mission of improving clinical outcomes and providing cost savings for customers.
NIMBUS, in combination with a radiofrequency generator and thermocouple probe, offers an efficient and effective solution for RF heat lesion procedures to alleviate pain. The technology has received FDA clearance and CE marking, demonstrating its safety and efficacy. Independent clinical studies have validated its ability to deliver durable and sustained pain relief while reducing procedure time.
Stratus Medical, headquartered in Magnolia, Texas, is dedicated to innovation in the field of pain management. With its expanded patent protection and ongoing development efforts, the company is well-positioned to make a significant impact in improving the lives of chronic pain patients globally.
Advantages of Stratus Medical’s NIMBUS technology include its ability to provide efficient and effective pain relief through RF heat lesion procedures. The technology has been cleared by regulatory bodies, demonstrating its safety and effectiveness. Independent studies have also validated the technology’s ability to deliver long-lasting pain relief while reducing procedure time. Stratus Medical’s dedication to research and development, as evidenced by its ongoing investment in technology, shows its commitment to improving clinical outcomes for chronic pain patients and providing cost savings for customers.
However, there are potential challenges and controversies associated with the subject. The article does not mention any specific challenges or controversies, but some common issues in the medical field include concerns about the long-term effectiveness of pain treatment technologies, potential side effects or complications, and ethical considerations related to the use of certain medical devices or procedures.
Further relevant market trends, forecasts, and key challenges or controversies would require additional research beyond the information provided in the article.